Page 11 - Read Online
P. 11

Page 208                                                             Lu et al. J Transl Genet Genom 2020;4:203-9  I  http://dx.doi.org/10.20517/jtgg.2020.33

               Conflicts of interest
               All authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2020.

               REFERENCES
               1.   Bondy B, Buettner A, Zill P. Genetics of suicide. Mol Psychiatry 2006;11:336-51.
               2.   Lu DY. Suicide risks and treatments, new ideas and future perspectives. New York, US: Nova Science Publishers; 2017.
               3.   Serafini G, Salano P, Amore M. Suicidal ideation: a comprehensive overview. Bradley Weaver. US: Nova Science Publishing; 2015. pp.
                   1-42.
               4.   Lu DY, Lu TR, Lu Y, Cao S. Introduction for suicide study. J Metab Syndr 2017;6:227.
               5.   Lu DY, Lu TR, Zhu PP, Che JY. The efficacies and toxicities of antidepressant drugs in clinics, building the relationship between Chemo-
                   Genetics and Socio-Environments. Cent Nerv Syst Agents Med Chem 2016;16:12-8.
               6.   Marreros A. Mood disorders: epidemiology and natural history. Psychiatry 2008;8:52-5.
               7.   Lu DY, Zhu PP, Wu HY, Yarla NS, Zhu H, et al. Human suicide study, is there an association between suicide and mental illness.
                   Metabolomics 2016;6:186.
               8.   Davison K. Historical aspects of mood disorders. Psychiatry 2006;5:115-8.
               9.   Lu DY, Wu HY, Cao S, Lu Y, Yarla NS, et al. Historical analysis of suicide/mental disorder and current diagnostics in clinics. Suicide
                   Risks and Treatments, New Ideas and Future Perspectives. New York, US: Nova Science Publishers; 2017. pp. 1-12.
               10.  Shandilya S. Suicide and suicide prevention: a historical review. Res J Social Sci 2018;9:35-40.
               11.  Azuero AJ, Arreaza-kaufman D, Caria J, Tasinari S, Faria A, et al. Suicide in the indigenous population of Latin America: a systematic
                   review. Availabel from: http://dx.doi.org/10.1016/j.rcp.2016.12.002. [Last accessed on 4 Jun 2020]
               12.  Fountoulakis KN. Suicide rate in Greece stabilizes at historically high levels but still lowest in Europe. J Affect Disord 2019;254:117-9.
               13.  Dhungel B, Sugai MK, Gilmour S. Trends in suicide mortality by methods from 1979 to 2016 in Japan. Int J Environmental Res Public
                   Health 2019;16:1794.
               14.  Kino S, Jang SN, Gero K, Kato S, Kawachi I. Age, period, cohort, trends of suicide in Japan and Korea (1986-2015): a tale of two
                   countries. Soc Sci Med 2019;235:112385.
               15.  McNicolas F. Suicide in Europe: an on-going public health concern. Soc Psihijat 2017;45:22-9.
               16.  Snowdon J, Phillips J, Zhong BL, Yamauchi T, Chiu HFK, et al. Changes in age patterns of suicide in Australia, the United States, Japan
                   and Hong Kong. J Affect Disord 2017;211:12-9.
               17.  Steelesmith D, Fontanella CA, Campo JV, Bridge JA, Warren KL, et al. Contextural factors associated with county-level suicide rates in
                   the United States, 1999 to 2016. JAMA 2019;2:e1910936.
               18.  Lu DY, Lu TR, Zhu PP, Che JY. Genetics and bioinformatics study of antidepressant drugs, recent advancements and future trends.
                   Bradley Weaver. US: Nova Science Publishing; 2015. pp. 57-71.
               19.  While D, Bickley H, Roscoe A, Windfuhr K, Rahman S, et al. Implementation of mental health service recommendations in England and
                   Wales and suicide rates, 1997-2006: a cross-sectional and before-and-after observational study. Lancet 2012;379:1005-12.
               20.  Frangou S. Brain structural changes in mood disorders. Psychiatry 2009;8:105-6.
               21.  Roiser JP, Rubinsztein JS, Sahakian BJ. Neuropsychology of affective disorders. Psychiatry 2009;8:91-6.
               22.  Frangou S. Functional neuroimaging in mood disorder. Psychiatry 2008;6:102-4.
               23.  Desmyter S, Bijttebier S, Heeringen KV. The role of neuroimaging in our understanding of the suicidal brain. CNS Neurol Disord Drug
                   Targets 2013;12:921-9.
               24.  Lu DY, Lu TR, Yarla NS, Wu HY. Genetics in suicide treatments, modern diagnosis establishments. J Mental Disord Treat 2017;3:145.
               25.  Kendell R. Diagnosis and classification of mood disorders. Psychiatry 2006;5:112-4.
               26.  Lu DY, Lu TR, Che JY, Zhu PP. Genetics and bioinformatics studies of antidepressant drug therapeutic efficacies and toxicities, a current
                   overview. Recent Pat CNS Drug Discov 2014;9:193-9.
               27.  McAllister-Williams R, Ferrier IN. Pharmacological management of unipolar affective disorder. Psychiatry 2009;8:113-9.
               28.  McAllister-Williams R, Ferrier IN. Pharmacological management of bipolar affective disorder. Psychiatry 2009;8:120-4.
               29.  Lucas, G. Fast-acting antidepressants: are we nearly there. Expert Rev Neurotherapeutics 2008;8:1-3.
               30.  Menchetti M, Bortolotti B, Rucci P, Scocco P, Bombi A, et al. Depression in primary care: Interpersonal counseling vs selective serotonin
                   reuptake inhibitors. The DEPICS study. A multicenter randomized controlled trial. Rationale and design. BMC Psychiatry 2010;10:97.
   6   7   8   9   10   11   12   13   14   15   16